The most promising applications are likely in cancers characterized by high replication stress, high proliferative indices, or those with specific dependencies on PCNA-mediated DNA repair pathways, such as triple-negative breast cancer, which tend to show stronger reliance on PCNA and thus greater vulnerability (Smith et al., 2015). The gene discussed is PCNA; the disease is cancer.